Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.40
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 1.50
High: 1.50
Low: 1.50
Prev. Close: 1.50
MAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

17 Dec 2015 07:00

RNS Number : 3395J
Marechale Capital PLC
17 December 2015
 

17 December 2015

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2015.

Chairman's Statement

Marechale's gross profit of £192,000 (2014 £228,000) is lower than the comparable period last year and, as a result, I report that the Company has made a loss before tax of £48,000 (2014 £46,000 loss) during the first half of the year. On the other hand, I am pleased to report that overheads have been reduced by almost 10% from £277,000 (2014) to £251,000.

Marechale's usual business cycle has traditionally resulted in the bulk of its revenues being generated in the second half of the financial year, and it appears at this stage that this will be the case in the current year.

During the first half Marechale has been appointed to raise growth and development capital for a series of client transactions, and whilst the Company has had a good deal flow, a number of its deals have taken, or are taking, longer to complete; all completed transactions are detailed on the Company's website at www.marechalecapital.com.

Marechale operates as a corporate finance advisory and capital fund raising business focusing on growth companies in two primary sectors in which the team have a long term track record; Leisure and Retail, and Renewable Energy.

Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital (private equity transactions for more established businesses) and Development Capital (fundraising for smaller growth companies), the latter typically being Enterprise Investment Scheme (EIS) qualifying.

Marechale's joint venture renewable energy company, Northfield UK Solar Limited ("Northfield"), established in July 2013, is developing a portfolio of solar sites. Northfield continues to have a challenging time as its first large scale solar project, whilst achieving the necessary Grid connection offer, was turned down in Planning, and the subsequent appeal has also failed, as announced on 6th November.

Northfield's second scheme has achieved Planning permission and has an agreed Grid connection offer. The project was supposed to be bid into the 2015 CfD auction, although it has recently been announced that there will be no solar subsidies in this year's auction. Solar has not been ruled out of other future auctions, and, because the scheme is not able to connect to the Grid until Q3/Q4 2017, there is a possibility that the site will receive the CfD. Also, whilst subsidy payments make a huge difference to the likely returns that this and Northfield's other projects, that are currently on hold, could achieve, there is potential value without them. Northfield is actively considering a number of other commercial opportunities, such as combining schemes with other renewable technologies that complement the solar projects and share in the costs, or selling to an EPC owner/operator who is looking to operate solar pv schemes without government support. Any such value would enhance Northfield's value, which would benefit Marechale and its shareholders as a result. We have again adjusted the value of Marechale's shareholding in Northfield on the Company's balance sheet to £146,000, to reflect the opportunity value and likely risks to this being achieved.

In addition, Marechale continues to work closely with its other renewable energy clients, and particularly with its anaerobic digestion EIS fund, which has recently installed and commissioned a 2MW AD plant in Norfolk. Marechale's client, Future Biogas Ltd, has now built or has in development a total of ten such plants in the UK, and is the UK's leading AD business.

In the Leisure and Retail sector, the Company has successfully completed a number of deals including raising additional EIS funding for Brewhouse & Kitchen, and acquiring a hotel in Majorca on behalf of one of its investor syndicates.

Marechale is a specialist adviser and funder to growth companies in the Leisure and Retail sector, and has successfully launched the Odexia Consumer Brand Fund, which invests in EIS qualifying food, drink and cosmetic growth brands. The first funding round has been completed and it hopes shortly to be able to announce its first investment in an exciting new ice cream brand.

We are taking steps to increase the Company's resources, and expect to announce a senior staff appointment in January 2016.

The Directors believe that backing the right growth companies, whilst not without its risks, represents an interesting private equity investment class for investors looking to diversify their portfolios; over the last five years investors in all Marechale's transactions would have achieved an IRR of over 20% per annum.

We will announce our full year's results in the summer of 2016.

 

Mark Warde-Norbury

Chairman

17 December 2015

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

Consolidated Income Statement (unaudited)

Six months ended 30 September 2015

30 Sept

30 Sept

2015

2014

£

£

Revenue

297,275

244,500

Cost of sales

(105,493)

(16,464)

Gross profit

191,782

228,036

Administrative expenses

(251,041)

(276,978)

Operating profit/ (loss)

(59,259)

(48,942)

Investment revenues

-

-

Other gains

5,005

2,999

Exceptional gain on dilution of interest in associate

5,726

135,759

Net (loss) in respect of associate

630

(21,607)

Provision for project loss in associate

-

(114,000)

(Loss) before tax

(47,898)

(45,791)

Taxation

-

(152)

(Loss) for the period

(47,898)

(45,943)

(Loss) per share

(Pence)

(Pence)

- Basic

(0.08)

(0.08)

- Diluted

(0.08)

(0.08)

 

 

 

 

Consolidated Balance Sheet (unaudited)

As at 30 September 2015

30 Sept

30 Sept

2015

2014

£

£

Non current assets

Investment in associate

146,150

119,845

Current assets

Available for sale investments

150,917

113,921

Trading investments

128,254

77,125

Trade and other receivables

210,226

89,226

Cash and cash equivalents

359,346

264,355

848,743

544,627

Total assets

994,893

664,472

Current liabilities

Trade and other payables

(193,696)

(57,568)

Total current liabilities

(193,696)

(57,568)

Net assets

801,196

606,904

Equity

Capital and reserves attributable to equity shareholders

Share capital

2,474,308

2,474,308

Share premium account

1,247,379

1,247,379

Revaluation reserve

88,885

51,889

Reserve for own shares

(50,254)

(50,254)

Retained losses

(2,968,196)

(3,116,418)

Reserve for share based payments

9,075

-

801,196

606,904

 

 

Consolidated Cash Flow Statement

Six months ended 30 September 2015

30 Sept

30 Sept

2015

2014

£

£

Net cash from operating activities

Operating (loss)

(59,259)

(48,942)

Provision for share based payments

-

-

Operating cash flows before movements in working capital

(59,259)

(48,942)

Movement in working capital

Decrease in receivables

280,882

131,777

(Decrease) in payables

(162,347)

(91,750)

118,536

40,027

Operating cash flow

59,277

(8,915)

Investment activities

Interest receivable

-

-

Proceeds on disposal of trading investments

5,005

-

Proceeds on disposal of available for sale investments

-

2,999

Expenditure on available for sale investments

-

(4,997)

Cash flow from investing activities

64,282

(10,913)

Financing

Issue of share capital

-

-

Interest payable

-

-

Cash flow from financing activities

-

-

Net increase/(decrease) in cash and cash equivalents

64,282

(10,913)

Cash and cash equivalents at start of the period

295,064

275,268

Cash and cash equivalents at end of the period

359,346

264,355

Increase/(Decrease) in cash and cash equivalents

64,282

(10,913)

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KQLFFELFEFBD
Date   Source Headline
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.